Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression

Figure 4

Effects of SLT treatment on the level of cytokines/chemokines in the brain after cerebral ischaemia. (a–f) Analysis showing the relative levels of the proinflammatory mediators IL-1α, IL-6, IL-12, and CXCL10 (IP-10) in the brain and in serum; (a–d) was in the brain; (e–h) was in serum. Data are expressed as the (). , , and vs. sham group; ^#, ^##, and ^### vs. the model groups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)